AAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO Tests

Written By :  sheeba farhat
Published On 2026-03-28 14:43 GMT   |   Update On 2026-03-28 14:43 GMT

New Delhi: AAP MP Vikramjit Singh Sahney on Friday raised the issue of spurious medicines and expressed serious concern over the rising threat of substandard and counterfeit medicines in the country.

During the zero hour in the Rajya Sabha, he said the issue of manufacture, sale and distribution of sub-standard drugs and medicines in India is quite an alarming matter.

Sahney demanded the setting up of the National Pharmaceutical Quality Authority to ensure uniform quality standards at the manufacturing and sale points.

He highlighted that last year, 203 pharmaceutical companies were found selling sub-standard and fortified drugs, and 36 per cent of the inspected drug factories were shut down, which were not meeting quality standards.

Central Drugs Standard Control Organisation’s (CDSCO) tests in 20 states found that 10 per cent more medicines were found to be of sub-standard quality, the AAP MP from Punjab highlighted.

The medicines included paracetamol, he said.

The majority of these companies were from Himachal Pradesh and Uttarakhand, and the majority of these small- and medium-sector firms.

There were reports of deaths of hundreds of children due to having cough syrups, he said.

Sahney also added that last year, over 1,500 samples were confiscated by the drug controller and some medicines were found to have materials like chalk powder, etc.

He said three lakh people die every year due to viral fever and taking antibiotic medicines, which are easily available over the counter, like toffee and chocolates, without any prescription.

In January to June last year, 1,500 samples of spurious medicines were taken into possession by the drug controller.

There is a pressing need to modernise and strengthen the Central Drug Controller (CDSCO), he stressed.

Also Read: NSQ Drug Alert: 60 Batches Including Paracetamol, Cefixime, Telmisartan Fail CDSCO Quality Tests in February

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News